FluMist Reimbursement Is Ahead Of Plan; TV Ads Will Begin Sept. 29

The initial coverage decisions for the FluMist nasal flu vaccine indicate that MedImmune and Wyeth will be able to maintain the $46 per dose price of the vaccine

More from Archive

More from Pink Sheet